(4-(1H-Imidazol-1-yl)phenyl)methanamine dihydrochloride, 95.0%, 1g

(S)-4-TERT-BUTYL-2-(2-PYRIDYL)OXAZOLINE, 98%, 5g

1-(PYRIDIN-4-YLMETHYL)-1,4-DIAZEPANE HCL, 95.0%, 100mg

2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 1g

((3R,4R)-4-Methylpyrrolidin-3-yl)methanolhydrochloride, 98%, 1g

Ethyl 3-(benzyl(methyl)amino)-2,2-difluoropropanoate, 95+%, 250mg

tert-Butyl 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 10g

(2,5-Dibromophenyl)(methyl)sulfane, 97%, 5g

(R)-4-(tert-Butyl)-2-(quinolin-8-yl)-4,5-dihydrooxazole, 97%, 100mg

2-CYANO-N-[4-(TRIFLUOROMETHYL)PHENYL]ACETAMIDE, 97.0%, 10g

6-BROMO-3-METHYLBENZOFURAN, 97%, 5g

Viales de muestra ROTILABO® con borde rebordeado, 4 ml, 200 Unidad(es)

7-Chloro-1-methyl-pyrazolo[4,3-b]pyridine, 97%, 100mg